SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VGNX -- Variagenics, Inc.
An SI Board Since March 2001
Posts SubjectMarks Bans Symbol
269 10 0 VGNX
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
219United States Patent Application 20020150943 Kind Code A1 Stanton, Vincent scaram(o)uche-11/11/2002
218the entire blurb from the website (be sure to get up and move around on long airscaram(o)uche-11/11/2002
217United States Patent 6,455,269 Toombs September 24, 2002 ----------------scaram(o)uche-11/11/2002
216Haemostasis 2001 May-Jun;31(3):141-7 Alfimeprase: pharmacology of a novel fibrscaram(o)uche-11/11/2002
215Rick fwiw think there are beter discounts available then vgnx right now :-) butdalroi-11/11/2002
214HYSQ is selling off on low volume. Their shareholders will by joyous with the dscaram(o)uche-11/11/2002
213thats simple arbitrage short hysq and perhaps start buying vgnx i've seen dalroi-11/11/2002
212Wish I had got up earlier when the price went over 2 bucks. Now Hysq is in downFindit-11/11/2002
211Hyseq and VARIAGENICS Announce Merger Monday November 11, 6:01 am ET - Buildinsmh-11/11/2002
210>> so two years more at the current burn....slow death? << I have ascaram(o)uche-11/6/2002
209so two years more at the current burn....slow death?mopgcw-11/6/2002
208VARIAGENICS Announces Third Quarter 2002 Results Wednesday November 6, 9:30 am Escaram(o)uche-11/6/2002
207United States Patent 6,458,945 Stanton, Jr. , et al. October 1, 2002 --scaram(o)uche-11/1/2002
206IDENTIFICATION OF GENETIC COMPONENTS OF DRUG RESPONSE Patent Number: Publicscaram(o)uche-11/1/2002
205Genotyping by mass spectrometric analysis of allelic fragments Patent Number: scaram(o)uche-11/1/2002
204VARIAGENICS Announces Licensing Agreement With Quest Diagnostics for Genetic Carscaram(o)uche-10/29/2002
203<i>bitter</i> ? <g> Just a little disappointed, that's alnigel bates-10/18/2002
202deletedscaram(o)uche-10/16/2002
201Jeez, bitter aren't we? They already found another one, remember the Arup dtuck-10/16/2002
200Alternative translation - "We got an offer from 'Dr. Rima Rozen, Presinigel bates-10/16/2002
199"We believe that Strida has a promising research plan to exploit this technscaram(o)uche-10/16/2002
198VARIAGENICS Announces License Option Agreement with Strida Pharma for Therapeutiscaram(o)uche-10/16/2002
197regarding today's Strida Pharma deal..... Mamm Genome 2002 Sep;13(9):483-92scaram(o)uche-10/16/2002
196Develops? >>CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 10, 2002--VARIAGENICStuck-10/10/2002
195<i>"talks about the Ivory Tower's bullsh*t dreams"??.....<nigel bates-10/5/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News